Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Androgen-independent Prostate Cancer”

129 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 129 results

Testing effectiveness (Phase 2)Study completedNCT00661492
What this trial is testing

Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)

Who this might be right for
Androgen-independent Prostate Cancer
US Oncology Research 115
Testing effectiveness (Phase 2)Study completedNCT00589420
What this trial is testing

Sorafenib and Docetaxel in Patients With Prostate Cancer That Did Not Respond to Previous Hormone Therapy

Who this might be right for
Prostate Cancer
Abramson Cancer Center at Penn Medicine 18
Testing effectiveness (Phase 2)Study completedNCT00106418
What this trial is testing

A Research Study for Patients With Prostate Cancer

Who this might be right for
Prostate CancerMetastases
Celgene 35
Testing effectiveness (Phase 2)Study completedNCT00181597
What this trial is testing

Trilostane for Androgen-Independent Prostate Cancer

Who this might be right for
Prostate CancerProstate Adenocarcinoma
Genzyme, a Sanofi Company 24
Not applicableEnded earlyNCT02055846
What this trial is testing

Analysis of the Mechanisms of Actions of Heat Shock Protein (Hsp27) Responsible of the Androgen-independent Evolution in Prostate Cancer

Who this might be right for
Androgen-independent Prostate Cancer
Institut Paoli-Calmettes 59
Testing effectiveness (Phase 2)Study completedNCT00520481
What this trial is testing

Study With IMC-A12 (Cixutumumab) in Patients Who Have Not Previously Been Treated With Chemotherapy With Metastatic Prostate Cancer

Who this might be right for
Adenocarcinoma of the Prostate
Eli Lilly and Company 41
Testing effectiveness (Phase 2)Study completedNCT01540071
What this trial is testing

Trial of NRX 194204 in Castration- and Taxane-Resistant Prostate Cancer

Who this might be right for
Castration Resistant Prostate Cancer
Io Therapeutics 38
Testing effectiveness (Phase 2)Study completedNCT00025194
What this trial is testing

Ixabepilone With or Without Estramustine in Treating Patients With Progressive Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00780975
What this trial is testing

Aplidin ( Plitidepsin) in Subjects With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
PharmaMar 8
Testing effectiveness (Phase 2)Study completedNCT00244998
What this trial is testing

Fulvestrant in Treating Patients With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Roswell Park Cancer Institute 20
Testing effectiveness (Phase 2)Study completedNCT00291005
What this trial is testing

PhII One Label Non-Comparative Trial in Metastatic Hormone Refractory Prostate Cancer in Combination With Prednisolone

Who this might be right for
Prostatic Neoplasms
Sanofi 42
Testing effectiveness (Phase 2)UnknownNCT00285675
What this trial is testing

Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004

Who this might be right for
Androgen Independent Prostate Cancer (AIPC)Non Small Cell Lung Cancer (NSCLC)
Novacea 25
Testing effectiveness (Phase 2)Study completedNCT00901342
What this trial is testing

Open Label Study of Sipuleucel-T in Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Dendreon 104
Testing effectiveness (Phase 2)Study completedNCT00436956
What this trial is testing

AZD2171 to Treat Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 59
Testing effectiveness (Phase 2)Study completedNCT00417274
What this trial is testing

Quinacrine Treatment in Patients With Androgen-Independent Prostate Cancer

Who this might be right for
Prostatic Cancer
Cleveland BioLabs 31
Testing effectiveness (Phase 2)Study completedNCT00134654
What this trial is testing

Two Doses of Conjugated Estrogen (Premarin) in Patients With Androgen-Independent Prostate Cancer

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute 48
Early research (Phase 1)Study completedNCT00032825
What this trial is testing

Ketoconazole Plus Docetaxel to Treat Prostate Cancer

Who this might be right for
Prostatic Neoplasms
National Cancer Institute (NCI) 674
Testing effectiveness (Phase 2)Study completedNCT00096499
What this trial is testing

SB-715992 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Docetaxel or Paclitaxel

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IV Prostate Cancer
National Cancer Institute (NCI) 40
Early research (Phase 1)Study completedNCT00113984
What this trial is testing

Vaccine and Antibody Treatment of Prostate Cancer

Who this might be right for
Prostatic Neoplasms
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT00078585
What this trial is testing

PROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy

Who this might be right for
Prostate Cancer
Bavarian Nordic 120
Load More Results